Global Neglected Tropical Diseases Diagnosis Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Neglected Tropical Diseases Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 5277.7 million by 2025, from USD 4833.1 million in 2019.
The Neglected Tropical Diseases Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neglected Tropical Diseases Diagnosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neglected Tropical Diseases Diagnosis market has been segmented into:
Conventional Method
Molecular/Modern Method
By Application, Neglected Tropical Diseases Diagnosis has been segmented into:
Clinical Labs
Hospitals /Clinics
Home Healthcare
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neglected Tropical Diseases Diagnosis market presented in the report. This section sheds light on the sales growth of different regional and country-level Neglected Tropical Diseases Diagnosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neglected Tropical Diseases Diagnosis market.
The report offers in-depth assessment of the growth and other aspects of the Neglected Tropical Diseases Diagnosis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Neglected Tropical Diseases Diagnosis Market Share Analysis
Neglected Tropical Diseases Diagnosis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neglected Tropical Diseases Diagnosis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neglected Tropical Diseases Diagnosis sales, revenue and market share for each player covered in this report.
The major players covered in Neglected Tropical Diseases Diagnosis are:
Abbott Laboratories
Siemens Healthcare
Life Technology
Beckman Coulter/Danaher
Premier Medical Corporation Ltd.
Bio-Rad Laboratories, Inc.
Ortho-Clinical Diagnostics
Novartis Diagnostics., Ltd.
Wako Chemicals, Inc.
Table of Contents
1 Neglected Tropical Diseases Diagnosis Market Overview
1.1 Product Overview and Scope of Neglected Tropical Diseases Diagnosis
1.2 Classification of Neglected Tropical Diseases Diagnosis by Type
1.2.1 Global Neglected Tropical Diseases Diagnosis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Type in 2019
1.2.3 Conventional Method
1.2.4 Molecular/Modern Method
1.3 Global Neglected Tropical Diseases Diagnosis Market by Application
1.3.1 Overview: Global Neglected Tropical Diseases Diagnosis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinical Labs
1.3.3 Hospitals /Clinics
1.3.4 Home Healthcare
1.4 Global Neglected Tropical Diseases Diagnosis Market by Regions
1.4.1 Global Neglected Tropical Diseases Diagnosis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Neglected Tropical Diseases Diagnosis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Neglected Tropical Diseases Diagnosis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Neglected Tropical Diseases Diagnosis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neglected Tropical Diseases Diagnosis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Neglected Tropical Diseases Diagnosis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neglected Tropical Diseases Diagnosis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Siemens Healthcare
2.2.1 Siemens Healthcare Details
2.2.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Siemens Healthcare SWOT Analysis
2.2.4 Siemens Healthcare Product and Services
2.2.5 Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Life Technology
2.3.1 Life Technology Details
2.3.2 Life Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Life Technology SWOT Analysis
2.3.4 Life Technology Product and Services
2.3.5 Life Technology Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beckman Coulter/Danaher
2.4.1 Beckman Coulter/Danaher Details
2.4.2 Beckman Coulter/Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beckman Coulter/Danaher SWOT Analysis
2.4.4 Beckman Coulter/Danaher Product and Services
2.4.5 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Premier Medical Corporation Ltd.
2.5.1 Premier Medical Corporation Ltd. Details
2.5.2 Premier Medical Corporation Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Premier Medical Corporation Ltd. SWOT Analysis
2.5.4 Premier Medical Corporation Ltd. Product and Services
2.5.5 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad Laboratories, Inc.
2.6.1 Bio-Rad Laboratories, Inc. Details
2.6.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.6.4 Bio-Rad Laboratories, Inc. Product and Services
2.6.5 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ortho-Clinical Diagnostics
2.7.1 Ortho-Clinical Diagnostics Details
2.7.2 Ortho-Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ortho-Clinical Diagnostics SWOT Analysis
2.7.4 Ortho-Clinical Diagnostics Product and Services
2.7.5 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis Diagnostics., Ltd.
2.8.1 Novartis Diagnostics., Ltd. Details
2.8.2 Novartis Diagnostics., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis Diagnostics., Ltd. SWOT Analysis
2.8.4 Novartis Diagnostics., Ltd. Product and Services
2.8.5 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Wako Chemicals, Inc.
2.9.1 Wako Chemicals, Inc. Details
2.9.2 Wako Chemicals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Wako Chemicals, Inc. SWOT Analysis
2.9.4 Wako Chemicals, Inc. Product and Services
2.9.5 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Neglected Tropical Diseases Diagnosis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Neglected Tropical Diseases Diagnosis Players Market Share
3.2.2 Top 10 Neglected Tropical Diseases Diagnosis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Neglected Tropical Diseases Diagnosis Revenue and Market Share by Regions
4.2 North America Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
4.3 Europe Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
4.5 South America Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
5 North America Neglected Tropical Diseases Diagnosis Revenue by Countries
5.1 North America Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
5.2 USA Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
5.3 Canada Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
5.4 Mexico Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
6 Europe Neglected Tropical Diseases Diagnosis Revenue by Countries
6.1 Europe Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
6.2 Germany Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
6.3 UK Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
6.4 France Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
6.5 Russia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
6.6 Italy Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Countries
7.1 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
7.2 China Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
7.3 Japan Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
7.4 Korea Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
7.5 India Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
8 South America Neglected Tropical Diseases Diagnosis Revenue by Countries
8.1 South America Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
8.2 Brazil Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
8.3 Argentina Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Neglected Tropical Diseases Diagnosis by Countries
9.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
9.3 UAE Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
9.4 Egypt Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
9.5 South Africa Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Neglected Tropical Diseases Diagnosis Revenue and Market Share by Type (2015-2020)
10.2 Global Neglected Tropical Diseases Diagnosis Market Forecast by Type (2019-2024)
10.3 Conventional Method Revenue Growth Rate (2015-2025)
10.4 Molecular/Modern Method Revenue Growth Rate (2015-2025)
11 Global Neglected Tropical Diseases Diagnosis Market Segment by Application
11.1 Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Application (2015-2020)
11.2 Neglected Tropical Diseases Diagnosis Market Forecast by Application (2019-2024)
11.3 Clinical Labs Revenue Growth (2015-2020)
11.4 Hospitals /Clinics Revenue Growth (2015-2020)
11.5 Home Healthcare Revenue Growth (2015-2020)
12 Global Neglected Tropical Diseases Diagnosis Market Size Forecast (2021-2025)
12.1 Global Neglected Tropical Diseases Diagnosis Market Size Forecast (2021-2025)
12.2 Global Neglected Tropical Diseases Diagnosis Market Forecast by Regions (2021-2025)
12.3 North America Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
12.4 Europe Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
12.6 South America Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Neglected Tropical Diseases Diagnosis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neglected Tropical Diseases Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neglected Tropical Diseases Diagnosis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Neglected Tropical Diseases Diagnosis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Neglected Tropical Diseases Diagnosis Major Business
Table 7. Abbott Laboratories Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Neglected Tropical Diseases Diagnosis Product and Solutions
Table 10. Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Siemens Healthcare Corporate Information, Location and Competitors
Table 12. Siemens Healthcare Neglected Tropical Diseases Diagnosis Major Business
Table 13. Siemens Healthcare Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2018-2019)
Table 14. Siemens Healthcare SWOT Analysis
Table 15. Siemens Healthcare Neglected Tropical Diseases Diagnosis Product and Solutions
Table 16. Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Life Technology Corporate Information, Location and Competitors
Table 18. Life Technology Neglected Tropical Diseases Diagnosis Major Business
Table 19. Life Technology Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 20. Life Technology SWOT Analysis
Table 21. Life Technology Neglected Tropical Diseases Diagnosis Product and Solutions
Table 22. Life Technology Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beckman Coulter/Danaher Corporate Information, Location and Competitors
Table 24. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Major Business
Table 25. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 26. Beckman Coulter/Danaher SWOT Analysis
Table 27. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product and Solutions
Table 28. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Premier Medical Corporation Ltd. Corporate Information, Location and Competitors
Table 30. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Major Business
Table 31. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 32. Premier Medical Corporation Ltd. SWOT Analysis
Table 33. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 34. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 36. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Major Business
Table 37. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 39. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 40. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ortho-Clinical Diagnostics Corporate Information, Location and Competitors
Table 42. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Major Business
Table 43. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 44. Ortho-Clinical Diagnostics SWOT Analysis
Table 45. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product and Solutions
Table 46. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Diagnostics., Ltd. Corporate Information, Location and Competitors
Table 48. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Major Business
Table 49. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 50. Novartis Diagnostics., Ltd. SWOT Analysis
Table 51. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 52. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Wako Chemicals, Inc. Corporate Information, Location and Competitors
Table 54. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Major Business
Table 55. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Total Revenue (USD Million) (2017-2018)
Table 56. Wako Chemicals, Inc. SWOT Analysis
Table 57. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product and Solutions
Table 58. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) by Players (2015-2020)
Table 60. Global Neglected Tropical Diseases Diagnosis Revenue Share by Players (2015-2020)
Table 61. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Regions (2015-2020)
Table 63. North America Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
Table 64. North America Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Table 65. Europe Neglected Tropical Diseases Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Neglected Tropical Diseases Diagnosis Revenue by Countries (2015-2020)
Table 68. South America Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Table 71. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) by Type (2015-2020)
Table 72. Global Neglected Tropical Diseases Diagnosis Revenue Share by Type (2015-2020)
Table 73. Global Neglected Tropical Diseases Diagnosis Revenue Forecast by Type (2021-2025)
Table 74. Global Neglected Tropical Diseases Diagnosis Revenue by Application (2015-2020)
Table 75. Global Neglected Tropical Diseases Diagnosis Revenue Share by Application (2015-2020)
Table 76. Global Neglected Tropical Diseases Diagnosis Revenue Forecast by Application (2021-2025)
Table 77. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Neglected Tropical Diseases Diagnosis Picture
Figure 2. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Type in 2019
Figure 3. Conventional Method Picture
Figure 4. Molecular/Modern Method Picture
Figure 5. Neglected Tropical Diseases Diagnosis Revenue Market Share by Application in 2019
Figure 6. Clinical Labs Picture
Figure 7. Hospitals /Clinics Picture
Figure 8. Home Healthcare Picture
Figure 9. Global Neglected Tropical Diseases Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Neglected Tropical Diseases Diagnosis Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Neglected Tropical Diseases Diagnosis Revenue Market Share in 2019
Figure 18. Global Top 10 Players Neglected Tropical Diseases Diagnosis Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Regions (2015-2020)
Figure 22. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Regions in 2018
Figure 23. North America Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 24. Europe Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 26. South America Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 28. North America Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 29. North America Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries in 2019
Figure 30. USA Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 31. Canada Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 33. Europe Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries in 2019
Figure 35. Germany Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 36. UK Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 37. France Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 38. Russia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 39. Italy Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries in 2019
Figure 42. China Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 43. Japan Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 44. Korea Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 45. India Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 47. South America Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 48. South America Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries in 2019
Figure 49. Brazil Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 54. UAE Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Neglected Tropical Diseases Diagnosis Revenue and Growth Rate (2015-2020)
Figure 57. Global Neglected Tropical Diseases Diagnosis Revenue Share by Type (2015-2020)
Figure 58. Global Neglected Tropical Diseases Diagnosis Revenue Share by Type in 2019
Figure 59. Global Neglected Tropical Diseases Diagnosis Market Share Forecast by Type (2021-2025)
Figure 60. Global Conventional Method Revenue Growth Rate (2015-2020)
Figure 61. Global Molecular/Modern Method Revenue Growth Rate (2015-2020)
Figure 62. Global Neglected Tropical Diseases Diagnosis Revenue Share by Application (2015-2020)
Figure 63. Global Neglected Tropical Diseases Diagnosis Revenue Share by Application in 2019
Figure 64. Global Neglected Tropical Diseases Diagnosis Market Share Forecast by Application (2021-2025)
Figure 65. Global Clinical Labs Revenue Growth Rate (2015-2020)
Figure 66. Global Hospitals /Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Home Healthcare Revenue Growth Rate (2015-2020)
Figure 68. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Neglected Tropical Diseases Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Neglected Tropical Diseases Diagnosis Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
Figure 72. Europe Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
Figure 74. South America Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Abbott Laboratories
Siemens Healthcare
Life Technology
Beckman Coulter/Danaher
Premier Medical Corporation Ltd.
Bio-Rad Laboratories, Inc.
Ortho-Clinical Diagnostics
Novartis Diagnostics., Ltd.
Wako Chemicals, Inc.
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets